Growth Metrics

Verastem (VSTM) Free Cash Flow Growth (3y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 24.91%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 20.11%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 14.71%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -10.65%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 31.42%
10 Verastem 425.60 Mn 243.93 Mn 15.90 Mn -36.96%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -36.96%
Dec 31, 2025 -21.71%
Sep 30, 2025 -33.91%
Jun 30, 2025 -37.03%
Mar 31, 2025 -26.12%
Dec 31, 2024 -36.20%
Sep 30, 2024 -30.01%
Jun 30, 2024 -27.12%
Mar 31, 2024 -13.23%
Dec 31, 2023 -11.00%
Sep 30, 2023 -33.37%
Jun 30, 2023 4.06%
Mar 31, 2023 15.83%
Dec 31, 2022 23.57%
Sep 30, 2022 18.49%
Jun 30, 2022 28.46%
Mar 31, 2022 20.78%
Dec 31, 2021 20.07%
Sep 30, 2021 22.52%
Jun 30, 2021 -7.73%
Mar 31, 2021 4.71%
Dec 31, 2020 -2.21%
Sep 30, 2020 79.24%
Jun 30, 2020 -15.89%
Mar 31, 2020 -47.26%
Dec 31, 2019 -84.24%
Sep 30, 2019 -66.63%
Jun 30, 2019 -73.04%
Mar 31, 2019 -53.03%
Dec 31, 2018 -23.97%
Sep 30, 2018 -26.06%
Jun 30, 2018 3.68%
Mar 31, 2018 -23.68%
Dec 31, 2017 -36.52%
Sep 30, 2017 -3.45%
Jun 30, 2017 -16.67%
Mar 31, 2017 -4.68%
Dec 31, 2016 3.21%
Sep 30, 2016 5.40%
Jun 30, 2016 -1.93%
Mar 31, 2016 -19.53%
Dec 31, 2015 -19.97%
Sep 30, 2015 -19.03%
Jun 30, 2015 -33.22%
Mar 31, 2015 -33.38%
Dec 31, 2014 -24.85%
Sep 30, 2014 -32.16%
Jun 30, 2014 -283.23%
Mar 31, 2014 -120.43%